🔴 Clearpoint Neuro is trading 10.05% down in pre-market — with no confirmed company explanation

Clearpoint Neuro is trading at $8.50, down 10.05% in pre-market; no confirmed company announcement directly explains the decline.

• Investor-law-firm notices about investigations appeared on October 20; they refer to the September 29 trial-data-related share decline and do not establish a cause for this move.
• The company’s next scheduled event is its third-quarter results announcement on October 28.
• The provided market context is positive and does not explain the stock’s decline.